1 / 4

CSRC COPD Initiative Think Tank Round Table Meeting

CSRC COPD Initiative Think Tank Round Table Meeting. March 6, 2014. A unique Patient Population. CSRC COPD Initiative:. There is a widely accepted link between COPD and Cardiovascular Diseases due to both diseases share common risk factors. A unique Drug Class: Broncodilatators.

kedem
Télécharger la présentation

CSRC COPD Initiative Think Tank Round Table Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CSRC COPD Initiative Think Tank Round Table Meeting March 6, 2014

  2. A unique Patient Population CSRC COPD Initiative: • There is a widely accepted link between COPD and Cardiovascular Diseases due to both diseases share common risk factors A unique Drug Class: Broncodilatators • With potential direct and indirect Cardiovascular effects • Most broncodilatators are Inhaled and Long acting compounds

  3. Unmet Needs CSRC COPD Initiative: • How to characterize those direct and indirect Cardio Vascular effects (shall we be pleased with HR, BP, Cardiac Arrhythmias …) • How to collect Cardio Vascular data Phase 2 and Phase 3 • Need of consistent Cardio Vascular Safety data suitable for pooling

  4. CSRC COPD Initiative Session 1: What is Specific in COPD Population Session 2: How to characterize CV Effects? Session 3: How to collect CV data during development Conclusions – Remarks Can we agree on a reasonable standard approach?

More Related